Elvitegravir - CAS# 697761-98-1 nidazole PubMed Central PMCID: PMC3547100

PubMed Central PMCID: PMC3547100

Purity: ≥98% (or refer to the Certificate of Analysis)

K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases

5H-cyclopenta[d']naphtho[1

Istaroxime increases intracellular calcium by improving the efficacy by which intracellular calcium triggers sarcoplasmic reticulum calcium release

Elvitegravir - CAS# 697761-98-1 nidazole PubMed Central PMCID: PMC3547100Elvitegravir, also known as GS 9137 ans EVG, is an integrase inhibitor used to treat HIV infection. The drug gained approval by the U. S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. Product information CAS Number: 697761 98 1 Molecular Weight: 447. 88 Formula: C23H23ClFNO5 Synonym: GS 9137 JTK 303 EVG D06677 Chemical Name: 6